Does propolis affect the quality of life and complications in subjects with irritable bowel syndrome (diagnosed with Rome IV criteria)? A study protocol of the randomized, double-blinded, placebo-controlled clinical trial

BACKGROUND: Irritable bowel syndrome (IBS) is one of the most frequent and recurrent gastrointestinal diseases. However, up to now, no pharmacological agent has been approved to treat IBS. Emerging evidence showed that inflammation has a vital role in enhancing nervous system sensitivity and percept...

Descripción completa

Detalles Bibliográficos
Autores principales: Miryan, Mahsa, Alavinejad, Pezhman, Abbaspour, Mohammadreza, Soleimani, Davood, Ostadrahimi, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405434/
https://www.ncbi.nlm.nih.gov/pubmed/32758282
http://dx.doi.org/10.1186/s13063-020-04615-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405434/
https://www.ncbi.nlm.nih.gov/pubmed/32758282
http://dx.doi.org/10.1186/s13063-020-04615-5

Ejemplares similares